Screener/Healthcare/Biotechnology

AMLX

Amylyx Pharmaceuticals, Inc.NASDAQ
$13.58+0.05 (+0.37%)
Small CapUnder $20HealthcareFastest Growing
$3.11
$17.49
$13.20
$13.70
EPS (TTM)$-1.53
P/E Ratio—
Dividend Yield—
Market Cap$1.17B
Volume644K
Prev Close$13.53
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$0-$33.0M$-0.28——
Q3 '25$0-$34.4M$-0.37——
Q2 '25$0-$41.4M$-0.46——
Q1 '25$0-$35.9M$-0.42——
Q4 '24-$665K-$37.5M$-0.54100.0%5646.0%
Q3 '24$416K-$72.7M$-1.07100.0%-17476.9%
Q2 '24-$1.0M-$72.7M$-1.07100.8%7106.5%
Q1 '24$88.6M-$118.8M$-1.7593.3%-134.0%
Get Your Daily Market Recap